Search Results - Sarker, D

Improving the outcome of patients with castration-resistant prostate cancer through rational drug development by Attard, G, Sarker, D, Reid, A, Molife, R, Parker, C, de Bono, J S

Get full text Get full text Get full text

P-115 Weight loss during 1st-line chemotherapy for upper gastrointestinal malignancies (UGI) may impact survival and access to further treatment lines by Oikonomopoulos, G., Payne, S., Ngan, S., Chowdhury, S., Hession, M., Sarker, D., Ross, P., Maisey, N.

Get full text Get full text

A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit by Brunetto, A T, Sarker, D, Papadatos-Pastos, D, Fehrmann, R, Kaye, S B, Johnston, S, Allen, M, De Bono, J S, Swanton, C

Get full text Get full text Get full text

P-098 Prognostic significance of comorbidities in elderly patients with Hepatocellular carcinoma (HCC) treated with Transarterial Chemoembolization: a Single Centre Experience by Aravind, P., Thillai, K., Suddel, A., Karani, J., Lewis, D., Heaton, N., Kane, P., Alkadhimi, G., Sarker, D., Ross, P.

Get full text Get full text

PD-021 A single centre experience of the prognostic variables in hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization by Aravind, P., Thillai, K., Heaton, N., Suddel, A., Kane, P., Karani, J., Peddu, P., Lewis, D., Alkadhimi, G., Sarker, D., Ross, P.

Get full text Get full text

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours by Turner, N C, Strauss, S J, Sarker, D, Gillmore, R, Kirkwood, A, Hackshaw, A, Papadopoulou, A, Bell, J, Kayani, I, Toumpanakis, C, Grillo, F, Mayer, A, Hochhauser, D, Begent, R H, Caplin, M E, Meyer, T

Get full text Get full text Get full text